Related Experiment Video
Updated: Feb 25, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Embolic Ischemic Stroke Associated with Maintenance Intravenous Immunoglobulin Therapy
Ryoji Miyano1, Yu Yoshida1, Kazuki Fujita1
1Department of Neurology, Jichi Medical University, Saitama Medical Center, Japan.
None:
We describe the case of a 51-year-old man who experienced an embolic ischemic stroke during long-term maintenance of intravenous immunoglobulin (IVIG) therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). At 43 years of age, he was diagnosed with CIDP and had tolerated IVIG well. Immediately after completing the 112th infusion, he exhibited acute right-hand clumsiness. Brain magnetic resonance imaging revealed an acute embolic infarction, and neither risk factors for ischemic stroke nor alternative embolic sources were identified. Although IVIG is generally considered safe, this case highlights that embolic stroke may occur even in relatively younger, low-risk patients during uneventful maintenance IVIG therapy, warranting continued vigilance.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Myocarditis III: Medical Management
Venous Thrombosis IV: Nursing Management
Myocarditis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

